Europe Q-PCR Reagents Market - Industry Trends and Forecast to 2030

Europe Q-PCR Reagents Market - Industry Trends and Forecast to 2030

Europe Q-PCR Reagents Market, By Detection Type (Dye-Based Reagents and Probe-Based Reagents), Assay Type (q-PCR singleplex test/assay and q-PCR multiplex test/assay), Plexity (Dye-Based Reagents, and Probe-Based Reagents), Packaging Type (Kits, and Master Mixers), Technology (Gene Expression, Gene Typing, MIRNA Analysis, Pre-Amplification, and Virus Detection), Application (Research, Diagnostics, and Forensic), End-User (Research & Academic Institute, Hospitals, Clinical Research Organization, Forensic Laboratories, and Others), Distribution Channel (Direct Tender, Third Party Distributors, and Others), Country (Germany, U.K., France, Italy, Spain, Netherlands, Switzerland, Belgium, Poland, Austria, Ireland, Hungary, Norway, Russia, Turkey, Lithuania, And Rest Of Europe) Industry Trends and Forecast to 2030.

Market Definition

Q-PCR reagents are used in the simultaneous amplification and detection/quantification of nucleic acids using the polymerase chain reaction (PCR). These reagents are used in different applications such as research, diagnosis, and forensics. They are also used for the detection of viruses, genetic stability testing, and others. The main advantage of q-PCR is that it allows you to determine the initial number of copies of template DNA (the amplification target sequence) with accuracy and high sensitivity over a wide dynamic range.

Market Segmentation

Europe Q-PCR Reagents Market is segmented into eight notable segment, which are based on the detection type, assay type, packaging type, plexity type, technology, application, end-user, and distribution channel.
• On the basis of detection type, the Europe q-PCR reagents market is segmented into dye-based reagents and probe-based reagents. Dye-based reagents are further segmented into the master mix, primers and DNA template. Probe-based reagents are further segmented into the master mix, primers and DNA template. In 2022, the probe-based reagents segment is expected to dominate the market due to its benefits over the dye-based, such as more exact results in lesser time than dye-based
• On the basis of assay type, the Europe q-PCR reagents market is segmented into q-PCR singleplex test/assay and q-PCR multiplex test/assay. In 2022, the q-PCR singleplex test/assay segment is expected to dominate the market due to the increasing chronic and communicable diseases
• On the basis of plexity type, the Europe q-PCR reagents market is segmented into dye-based reagents and probe-based reagents. Dye-based reagents are further segmented into singleplex and multiplex. Probe-based reagents are further segmented into singleplex and multiplex. In 2022, the dye-based reagents segment is expected to dominate the market due to its benefits and advantages over other reagents
• On the basis of packaging type, the Europe q-PCR reagents market is segmented into kits and master mixes. In 2022, the kits segment is expected to dominate the market due to the accessibility of core kits across the major countries, minimal prices, expanding private-public finance for life science research, and suppleness offered to end-users
• On the basis of technology, the Europe q-PCR reagents market is segmented into gene expression, gene typing, MIRNA analysis, pre-amplification, and virus detection. In 2022, the gene expression segment is expected to dominate the market due to its credible precision and high-throughput competence
• On the basis of application, the Europe q-PCR reagents market is segmented into diagnostics, research, and forensics. In 2022, the forensic application is expected to dominate the market due to mounting frequencies of criminal cases and increasing laboratory automation in forensic laboratories
• On the basis of end user, the Europe q-PCR reagents market is segmented into hospital & diagnostic centers, forensic laboratories, research & academic institute, clinical research organization and others. In 2022, the hospital & diagnostic centers segment is expected to dominate the market due to the immense amount of diagnosis and testing required to support disease discovery and development
• On the basis of distribution channel, the Europe q-PCR reagents market is segmented into direct tender, third-party distributors and others. In 2022, direct tender is expected to dominate the Europe q-PCR reagents market as direct tender is an easy process that does not involve any other medium for supply

Market Players

Some of the key players operating in the Europe Q-PCR reagents market are:
• Bio-Rad Laboratories, Inc.
• Agilent Technologies, Inc.
• Biotium
• MiRXES Pte Ltd.
• GeneDireX, Inc.
• F. Hoffmann-La Roche Ltd.
• Norgen Biotek Corp.
• Takara Holdings Inc.
• Enzo Biochem Inc
• Qiagen.
• PCR Biosystems,
• Quantabio
• Merck KgaA.
• Kaneka Eurogentec S.A.
• Promega Corporation.
• Solis BioDyne
• Seegene Inc.
• Sino Biological Inc
• Thermo Fisher Scientific Inc.
• New England Biolabs,
• YouSeq Ltd
• Bioneer Corporation.